Niskocząsteczkowe inhibitory plazminy

• Autorzy: Midura-Nowaczek K.

Warianty tytułu

EN

Low molecular inhibitors of plasmin

• Języki publikacji: PL

Abstrakty

EN

Plasmin, serine protease with trypsin specifity, plays a key role in the process of fibrinolysis. Analogs of lysine like e-aminocaproic acid and trans-4-aminomethylclohexanecarboxylic acid are employed clinically as plasmin inhibitors and exhibit an inhibitory effect by blocking lysine binding sites of the enzyme. Their inhibitory activity on plasmin with the respect to fibrinogen and other proteins is much weaker than towards fibrin. Because of this reason investigations on the synthesis of an active centre directed inhibitors of plasmin were also undertaken. A great number of compounds was obtained including derivatives of w-aminoacids or lysine. Next important group were short peptides with C-terminal lysine or arginine derivatives such as aldehydes, chloromethylketones, fluoromethylketone, methylketones, amides or esters. This paper presents literature data on structure-activity relationship for low molecular inhibitors of plasmin with a structure of aminoacids or peptides derivatives.

Słowa kluczowe

PL

plazmina; inhibitor; fibryna; antyfibrynolityki; lizyna; aminokwasy

EN

plasmin; inhibitor; fibrin; lysine; amino acids

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Wiadomości Chemiczne
• Rocznik: 1998
• Tom: [Z] 52, 11-12
• Strony: 871--887
• Opis fizyczny: Bibliogr. 52 poz., rys., schem.

Twórcy

autor

Midura-Nowaczek K.

• Instytut Chemii, Uniwersytet w Białymstoku, ul. J. Pułsudskiego 11/4, 15-443 Białystok

Bibliografia

• [1] M. Forsgren, B. Raden, M. Israelsson, K. Larsson, L. O. Heden, FEBS Lett., 1987, 213, 254.
• [2] J. L. Hoover-Plow, L. A. Miles, G. M. Fless, A. M. Scanu, E. F. Plow, Biochemistry, 1993, 32, 13681.
• [3] P. Friberger, Scand. J. Clin. Lab. Ivest. (Suppl. 162), 1982, 42, 49.
• [4] E. E. Rickli, Thrombose und Hämostaseforschung, F. K. Schattauer Verlag, Stuttgart-New York, 984, 13.
• [5] K. Midura-Nowaczek, I. Bruzgo, Wiad. Chem., 1987, 41, 705.
• [6] M. Verstraete, Drugs, 1985, 29, 236.
• [7] E S. Winn, S. P. Hu, S. M. Hochswender, R. A. Laursen, Eur. J. Biochem., 1980, ] 579.
• [8] K. Midura-Nowaczek, I. Bruzgo, E. Dubis, W. Roszkowska-Jakimiec, K. V rowski, Pharmazie, 1996, 51, 775.
• [9] D. G. Deutsch, E. T. Mertz, Science, 1970, 170, 1095.
• [10] D. Marti, J. Schaller, B. Ochensberger, E. E. Rickli, Eur. J. Biochem., 1994
• [11] L1. Mathews, P. Vanderhoff-Hanaver, F. J. Castellino, A. Tulinsky, Bio 1996, 35, 257.
• [12] T. P. Wu, K. Padmanabhan, A. Tulinsky, A. M. Mulichak, ibid., 1991
• [13] M. R. Rejante, M. Llinas, Eur. J. Biochem., 1994, 221, 939.
• [14] M. R. Rejante, I. J. Byeon, M. Llinas, Biochemistry, 1991, 30, 11081.
• [15] N. Teno, K. Wanaka, Y. Okada, H. Taguchi, U. Okamoto, A. Hijikata-Okuno- miya, S. Okamoto, Chem. Pharm. Bull., 1993, 41, 1079.
• [16] K. Midura-Nowaczek, I. Bruzgo, W. Roszkowska-Jakimiec, K. Worowski, Acta Polon. Pharim, 1996, 53, 221.
• [17] H. Umezawa, T. Aoyagi, Proteinoses in Mammalian Cells and Tissues, Elsevier/North- Holland Biomedical Press 1977, 637.
• [18] R. C. Thompson, Biochemistry, 1973, 12, 47.
• [19] C. Chi, H. Liu, B. A. K. Chibber, F. J. Castellino, J. Antibiot., 1989, 42, 1506.
• [20] G. Borin, G. Chessa, G. Cavaggion, F. Marchiori, W. Müller-Esterl, Hoppe-Sey- ler’s Z. Physiol. Chem., 1981, 362, 1435.
• [21] T. Saino, T. Someno, S. Ishii, T. Aoyagi, H. Umezawa, J. Antibiot., 1988, 41, 220.
• [22] R. M. Me Connel, G. E. Barnes, C. F. Hoyng, J. M. Gunn, J. Med. Chem., 1990, 33, 86.
• [23] R. M. Me Connel, L. J. York, D. Frizzel, C. Ezell, ibid., 1993, 36, 1084.
• [24] S. Bajusz, E. Szell, E. Barabas, D. Bagdy, Peptides: Synthesis - Structure - Function, red. Rich D. H. and Gross E, Pierce Chem. Co., Rockford, Illinois, 1981, 417.
• [25] S. Bajusz, E. Szell, F. Barabas, D. Bagdy, Folia Haematol., 1982, 109, 16.
• [26] C. Kettner, E. Shaw, Biochemistry, 1978, 17, 4778.
• [27] C. Kettner, E. Shaw, Methods Enzymol., 1981, 80, 826.
• [28] V. S. Ganu, E. Shaw, Thromb. Res., 1987, 45, 1.
• [29] D. Collen, H. R. Lijnen, F. De Cock, J. P. Durieux, A. Loffet, Biochim. Biophys. Acta, 1980, 615, 158.
• [30] H. R. Lijnen, M. Uyetterhoeven, D. Collen, Thromb. Res., 1984, 34, 413.
• [31] H. Angliker, P. Wirksom, P. Räuber, E. Shaw, Biochem. J, 1987, 241, 871.
• [32] P. Räuber, B. Walker, S. Stone, E. Shaw, ibid., 1988, 250, 871.
• [33] K. Midura-Nowaczek, I. Bruzgo, W. Roszkowska-Jakimiec, K. Worowski, Farmaco., 1997, 52, 35.
• [34] J. S. Me Murray, D. F. Dyckes, Biochemistry, 1986, 25, 2298.
• [35] A. Nagamatsu, T. Okuma, M. Watanabe, Y. Yamamura, J. Biochem., 1963, 54, 491.
• [36] A. Nagamatsu, T. Okuma, T. Hayashida, Y. Yamamura, Chem. Pharm. Bull., 1968, 16, 211.
• [37] Y. Okada, Y. Tsuda, N. Teno, K. Wanaka, M. Boghaki, A. Hijikata-Okunomija, T. Naito, S. Okamoto, ibid., 1988, 36, 1289.
• [38] S. Okamoto, U. Okamoto, Y. Okada, A. Hijikata-Okunoiya, K. Wanaka, N. Horie, T. Naito, Fundamental and Clinical Fibrinolysis, Elsevier Science Publisher B. V. (Biomedical division), rozdz. 6, 1987, 67.
• [39] L. Skoza, A. O. Tse, M. Semar, A. J. Johnson, Ann. N. Y. Acad. Sei., 1968, 146, 659.
• [40] J. Fareed, H. L. Messmore, G. Kindel, J. U. Balis, ibid., 1981, 370, 765.
• [41] K. Midura-Nowaczek, I. Bruzgo, W. Roszkowska-Jakimiec, K. Worowski, Acta Polon. Pharm., 1990, 47, 39.
• [42] U. Christensen, Biochem. J. 1984, 223, 413.
• [43] T. Thewes, K. Constantine, I. J. L. Byegon, M. Llinas, J. Biol. Chem., 1990, 265, 3906.
• [44] R. A. Galemmo Jr, J. M. Fevig, D. J. Carini, J. Cacciola, B. L. Wells, G. L. Hillyer, J. Buriak Jr, K. A. Rossi, P. F. W. Stouten, R. S. Alexander, R. Hilmer, L. Bostrom, M. M. Abelman, S.-L. Lee, P. C. Weber, Ch. A. Ketter, R. M. Knabb, R. R. Wexler, Bioorg. Med. Chem., Let., 1996, 6, 2913.
• [45] F. F. Markwardt, Handbook of Experimental Pharmacology, Vol. 46, Fibrinolytics and Antifibrynolytics, Springer, Berlln-Heidelberg-New York 1978, 511.
• [46] T. Nakayama, S. Taira, M. Ikeda, M. Ashizawa, M. Oda, K. Akarawa, S. Fuji, Chem. Pharm. Bull., 1993, 41, 117.
• [47] H. Akashi, T. Ariki, M. Kato, Y. Kozaki, T. Irisawa, M. Muramatu, Biol. Pharm. Bull., 1994, 17, 446.
• [48] K. Senokuchi, H. Nakai, Y. Nakayama, Y. Ogadaki, K. Sakaki, M. Kato, T. Ma- ruyama, T. Miyazaki, H. Ito, K. Kamiyasu,S. Kim, M. Kawamura, N. Hamanaka, J. Med. Chem., 1995, 38, 2521.
• [49] R. Rai, J. A. Katzenellenbogen, ibid., 1992, 35, 4150.
• [50] J. A. Katzenellenbogen, R. Rai, W. Dai, Bioorg. Med. Chem. Lett., 1992, 2, 1399.
• [51] A. A. R. Higazi, M. Mayer, Biochem. J., 1989, 260, 609.
• [52] R. P. Saxena, O. P. Gulati, K. C. Saxena, Chanan Singh, Y. S. Prabhakar, A. K. Sa¬xena, Curr. Sei., 1977, 73, 198 (C.A. 127:229224q).

Uwagi

PL

Opracowanie rekordu ze środków MNiSW, umowa nr SONP/SP/546092/2022 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2024).